M&A Corner
Ipsen Extends Expiration Date of Tender Offer for Albireo Pharma, Inc. to 1 March 202327 Feb 2023
Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Anemone Acquisition Corp. (Purchaser), its wholly owned indirect subsidiary, has extended... Continue Reading
|
Transcend Therapeutics, a Mental Health-focused Biotechnology Company, Announces Series a Funding Round of $40 Million Led By Alpha Wave Global and Integrated Investment Partners27 Feb 2023
Transcend Therapeutics, a biotechnology company that develops medicines to treat neuropsychiatric diseases, including post-traumatic stress disorder (PTSD), today announced that... Continue Reading
|
Vytalize Health Closes $100M to Support Value-based Care Transformatio27 Feb 2023
What You Should Know: – Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in... Continue Reading
|
UnitedHealth Closes $5.4 Billion Deal with LHS27 Feb 2023
UnitedHealth Group’s acquisition of home health company LHC Group has formally closed, according to Seeking Alpha. The deal had tentatively... Continue Reading
|
Axena Health Raises $25M to Support Pelvic Floor Digital Therapeutic27 Feb 2023
Axena Health, which makes a women’s pelvic health digital therapeutic, announced it had raised a $25 million Series A investment... Continue Reading
|
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials27 Feb 2023
What You Should Know: – Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer,... Continue Reading
|
Dawn Health, Novartis Partner to Develop Chronic Condition Management Tools27 Feb 2023
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management... Continue Reading
|
Mark Cuban Cost Plus Drug Company Partners with Diabetes Management Platform27 Feb 2023
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with diabetes and chronic disease management company Diathrive Health to provide... Continue Reading
|
Apax Partners Acquires a Majority Stake in Porsolt to Support Its Growth Strategy to Become a Global Leader in Preclinical Services.27 Feb 2023
Apax Partners, a leading European private equity firm, is excited to announce that it has acquired a majority stake in... Continue Reading
|
Mainz Biomed Acquires Entire Intellectual Property Portfolio for Its Colorectal Cancer Diagnostic Test Program27 Feb 2023
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of... Continue Reading
|